Ownership history in Bellevue Group AG · 40 quarters on record
This page tracks every 13F SEC filing in which Bellevue Group AG reported a position in Edwards Lifesciences Corporation (EW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,043,096 | +146,463 | +16.3% | 1.69% | $88.9M | $85.25 |
| 2025 Q3 | ADDED | 896,633 | +7,556 | +0.8% | 1.45% | $69.7M | $77.77 |
| 2025 Q2 | REDUCED | 889,077 | -82,892 | -8.5% | 1.53% | $69.5M | $78.21 |
| 2025 Q1 | REDUCED | 971,969 | -125,879 | -11.5% | 1.58% | $70.4M | $72.48 |
| 2024 Q4 | REDUCED | 1,097,848 | -36,228 | -3.2% | 1.56% | $81.3M | $74.03 |
| 2024 Q3 | REDUCED | 1,134,076 | -126,385 | -10.0% | 1.21% | $74.8M | $65.99 |
| 2024 Q2 | ADDED | 1,260,461 | +157,325 | +14.3% | 1.89% | $116.4M | $92.37 |
| 2024 Q1 | ADDED | 1,103,136 | +84,138 | +8.3% | 1.61% | $105.4M | $95.56 |
| 2023 Q4 | REDUCED | 1,018,998 | -6,459 | -0.6% | 1.19% | $77.7M | $76.25 |
| 2023 Q3 | REDUCED | 1,025,457 | -12,635 | -1.2% | 1.14% | $71.0M | $69.28 |
As of 2025 Q4 — sorted by position size